Tesirine is part of the antibody-drug conjugate loncastuximab tesirine-lpyl (Zynlonta), used to treat relapsed or refractory adult large B-cell lymphoma (DLBCL) after at least two prior systemic therapies. It targets CD19 proteins on lymphoma cells, delivering the tesirine chemotherapy drug directly to cancer cells to kill them. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include Zynlonta. Its PubChem CID is 73672523.
Tesirine
| CAS No | 1595275-62-9 |
|---|---|
| Molecular Formula | C75H101N9O23 |
| Molecular Weight | 1496.6 g/mol |
| Synonyms | [4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl (6S,6aS)-3-[5-[[(6aS)-2-methoxy-8-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-6-hydroxy-2-methoxy-8-methyl-11-oxo-6a,7-dihydro-6H-pyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tesirine is part of the antibody-drug conjugate loncastuximab tesirine-lpyl (Zynlonta), used to treat relapsed or refractory adult large B-cell lymphoma (DLBCL) after at least two prior systemic therapies.
The listed CAS number is 1595275-62-9.
The listed molecular formula is C75H101N9O23.
The listed molecular weight is 1496.6 g/mol.
The source lists Zynlonta.
It is listed as a under development API with a synthetic origin.